Pages that link to "Q24655932"
Jump to navigation
Jump to search
The following pages link to Antibody recognition of a highly conserved influenza virus epitope (Q24655932):
Displaying 50 items.
- Broadly protective monoclonal antibodies against H3 influenza viruses following sequential immunization with different hemagglutinins (Q21131563) (← links)
- New class of monoclonal antibodies against severe influenza: prophylactic and therapeutic efficacy in ferrets (Q21142658) (← links)
- Broadly neutralizing hemagglutinin stalk-specific antibodies require FcγR interactions for protection against influenza virus in vivo (Q24568302) (← links)
- Therapeutic antibodies, vaccines and antibodyomes (Q24599662) (← links)
- Vaccination with a synthetic peptide from the influenza virus hemagglutinin provides protection against distinct viral subtypes (Q24614628) (← links)
- A highly conserved neutralizing epitope on group 2 influenza A viruses (Q24630467) (← links)
- Current Landscape of Antiviral Drug Discovery (Q26766639) (← links)
- Stable long-term cultures of self-renewing B cells and their applications (Q26766723) (← links)
- Developing Universal Influenza Vaccines: Hitting the Nail, Not Just on the Head (Q26783897) (← links)
- The role of Fc-FcγR interactions in IgG-mediated microbial neutralization (Q26797466) (← links)
- Antibody-Based Strategies to Prevent and Treat Influenza (Q26798520) (← links)
- B Cells and Functional Antibody Responses to Combat Influenza (Q26801639) (← links)
- Structural characterization of viral epitopes recognized by broadly cross-reactive antibodies (Q26823492) (← links)
- Advances in structure-based vaccine design (Q26824545) (← links)
- Potential strategies and biosafety protocols used for dual-use research on highly pathogenic influenza viruses (Q26825532) (← links)
- Recent progress in structure-based anti-influenza drug design (Q26863710) (← links)
- Universal immunity to influenza must outwit immune evasion (Q26991896) (← links)
- H5N1 vaccines in humans (Q27000896) (← links)
- Influenza virus hemagglutinin stalk-based antibodies and vaccines (Q27001190) (← links)
- Broadly neutralizing antibodies against influenza virus and prospects for universal therapies (Q27010503) (← links)
- HIV-1 envelope glycoprotein structure (Q27011248) (← links)
- How specific is too specific? B-cell responses to viral infections reveal the importance of breadth over depth (Q27026728) (← links)
- Matrix-M Adjuvated Seasonal Virosomal Influenza Vaccine Induces Partial Protection in Mice and Ferrets against Avian H5 and H7 Challenge (Q27300233) (← links)
- Mechanisms of hemagglutinin targeted influenza virus neutralization (Q27302234) (← links)
- Computable features required to evaluate the efficacy of drugs and a universal algorithm to find optimally effective drug in a drug complex (Q27306357) (← links)
- Single-Dose Mucosal Immunization with a Candidate Universal Influenza Vaccine Provides Rapid Protection from Virulent H5N1, H3N2 and H1N1 Viruses (Q27318575) (← links)
- Microbial Cryptotopes are Prominent Targets of B-cell Immunity (Q27468862) (← links)
- Vaccines: the Fourth Century (Q27490454) (← links)
- Monoclonal antibody-based therapies for microbial diseases (Q27490830) (← links)
- Ebolavirus glycoprotein structure and mechanism of entry (Q27490991) (← links)
- Vaccine-Induced Antibodies that Neutralize Group 1 and Group 2 Influenza A Viruses (Q27644544) (← links)
- Structure, Receptor Binding, and Antigenicity of Influenza Virus Hemagglutinins from the 1957 H2N2 Pandemic (Q27646580) (← links)
- Structure and Receptor binding properties of a pandemic H1N1 virus hemagglutinin (Q27660366) (← links)
- Computational design of epitope-scaffolds allows induction of antibodies specific for a poorly immunogenic HIV vaccine epitope (Q27664365) (← links)
- Crystal structure of the swine-origin A (H1N1)-2009 influenza A virus hemagglutinin (HA) reveals similar antigenicity to that of the 1918 pandemic virus (Q27666458) (← links)
- Structural Characterization of an Early Fusion Intermediate of Influenza Virus Hemagglutinin (Q27667137) (← links)
- Computational Design of Proteins Targeting the Conserved Stem Region of Influenza Hemagglutinin (Q27667831) (← links)
- Structure-based approach to rationally design a chimeric protein for an effective vaccine against Group B Streptococcus infections (Q27667893) (← links)
- A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins (Q27671165) (← links)
- Highly Conserved Protective Epitopes on Influenza B Viruses (Q27671404) (← links)
- Cross-neutralization of influenza A viruses mediated by a single antibody loop (Q27673206) (← links)
- Insights into Avian Influenza Virus Pathogenicity: the Hemagglutinin Precursor HA0 of Subtype H16 Has an Alpha-Helix Structure in Its Cleavage Site with Inefficient HA1/HA2 Cleavage (Q27673446) (← links)
- Heterosubtypic antibody recognition of the influenza virus hemagglutinin receptor binding site enhanced by avidity (Q27673861) (← links)
- Preconfiguration of the antigen-binding site during affinity maturation of a broadly neutralizing influenza virus antibody (Q27675207) (← links)
- Influenza Human Monoclonal Antibody 1F1 Interacts with Three Major Antigenic Sites and Residues Mediating Human Receptor Specificity in H1N1 Viruses (Q27675477) (← links)
- A shared structural solution for neutralizing ebolaviruses (Q27675675) (← links)
- Hemagglutinin homologue from H17N10 bat influenza virus exhibits divergent receptor-binding and pH-dependent fusion activities (Q27675808) (← links)
- Acid Stability of the Hemagglutinin Protein Regulates H5N1 Influenza Virus Pathogenicity (Q27676000) (← links)
- A recurring motif for antibody recognition of the receptor-binding site of influenza hemagglutinin (Q27676298) (← links)
- Structural vaccinology: structure-based design of influenza A virus hemagglutinin subtype-specific subunit vaccines (Q27676658) (← links)